Bulk Raws- Raloxifene (Evista)

a SERM approved by the U.S. Food and Drug Administration (FDA) to: reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women who haven’t been diagnosed but are at higher-than-average risk for disease.